Immunotherapy in the Peri-Operative Setting of HNSCC – OncLive
OncLive |
Immunotherapy in the Peri-Operative Setting of HNSCC
OncLive And I think in the next year, we're going to get a flurry of safety data on combinations of immunotherapy and radiation that will then empower efficacy design studies to ask, how should we do that? Should it be in combination with platinum and radiation? |
